4/A
Changes in Ownership
RESMED INC Filed Acc 0001127602-23-028095
Chief Executive Officer gave up 3,695.93 shares (to pay taxes)
- Chief Executive Officer acquired 3,462 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Farrell Michael J. · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-16 | Exercise or conversion : show line 1 in the form | +3,462 | $57.76 | $199,965 | 444,448 | D |
| 2023-11-16 | Shares withheld for taxes : show line 2 in the form | −1,343 | $148.90 | $199,973 | 443,105 | D |
| 2023-11-20 | Shares withheld for taxes : show line 3 in the form | −2,352.93 | $148.94 | $350,445 | 440,752 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-16 | Exercise or conversion : show line 4 in the form ResMed Common Stock Options | −3,462 | 0 | D | ||
| 2023-11-16 | Grant or award : show line 5 in the form ResMed Common Stock Options | +55,468 | $148.90 | $8,259,185 | 55,468 | D |
Loading xslF345X05/form4a.xml…